VIR Vir Biotechnology, Inc.
Vir Biotechnology, Inc. (VIR) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $26.7K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| de Verneuil Vanina | EVP, General Counsel, Corp Sec | Sell 10b5-1 | 2,407 | $11.10 | $26.7K | 110,193 −2.1% of holding | |
| de Verneuil Vanina | EVP, General Counsel, Corp Sec | Sell 10b5-1 | 1,343 | $11.33 | $15.2K | 112,600 −1.2% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.